IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0252874.html
   My bibliography  Save this article

Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus disease

Author

Listed:
  • Nancy A Niemuth
  • Dawn Fallacara
  • Cheryl A Triplett
  • Sanjay M Tamrakar
  • Alisha Rajbhandari
  • Clint Florence
  • Lucy Ward
  • Anthony Griffiths
  • Ricardo Carrion Jr.
  • Yenny Goez-Gazi
  • Kendra J Alfson
  • Hilary M Staples
  • Trevor Brasel
  • Jason E Comer
  • Shane Massey
  • Jeanon Smith
  • Andrew Kocsis
  • Jake Lowry
  • Sara C Johnston
  • Aysegul Nalca
  • Arthur J Goff
  • Amy C Shurtleff
  • Margaret L Pitt
  • John Trefry
  • Michael P Fay

Abstract

Filoviruses (Family Filoviridae genera Ebolavirus and Marburgvirus) are negative-stranded RNA viruses that cause severe health effects in humans and non-human primates, including death. Except in outbreak settings, vaccines and other medical countermeasures against Ebola virus (EBOV) will require testing under the FDA Animal Rule. Multiple vaccine candidates have been evaluated using cynomolgus monkeys (CM) exposed to EBOV Kikwit strain. To the best of our knowledge, however, animal model development data supporting the use of CM in vaccine research have not been submitted to the FDA. This study describes a large CM database (122 CM, 62 female and 60 male, age 2 to 9 years) and demonstrates the consistency of the CM model through time to death models and descriptive statistics. CMs were exposed to EBOV doses of 0.1 to 100,000 PFU in 33 studies conducted at three Animal Biosafety Level 4 facilities, by three exposure routes. Time to death was modeled using Cox proportional hazards models with a frailty term that incorporated study-to-study variability. Despite significant differences attributed to exposure variables, all CMs exposed to the 100 to 1,000 pfu doses commonly used in vaccine studies died or met euthanasia criteria within 21 days of exposure, median 7 days, 93% between 5 and 12 days of exposure. Moderate clinical signs were observed 4 to 5 days after exposure and preceded death or euthanasia by approximately one day. Viremia was detected within a few days of infection. Hematology indices were indicative of viremia and the propensity for hemorrhage with progression of Ebola viremia. Changes associated with coagulation parameters and platelets were consistent with coagulation disruption. Changes in leukocyte profiles were indicative of an acute inflammatory response. Increased liver enzymes were observed shortly after exposure. Taken together, these factors suggest that the cynomolgus monkey is a reliable animal model for human disease.

Suggested Citation

  • Nancy A Niemuth & Dawn Fallacara & Cheryl A Triplett & Sanjay M Tamrakar & Alisha Rajbhandari & Clint Florence & Lucy Ward & Anthony Griffiths & Ricardo Carrion Jr. & Yenny Goez-Gazi & Kendra J Alfson, 2021. "Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus disease," PLOS ONE, Public Library of Science, vol. 16(7), pages 1-31, July.
  • Handle: RePEc:plo:pone00:0252874
    DOI: 10.1371/journal.pone.0252874
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0252874
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0252874&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0252874?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0252874. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.